CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML

MLA

Bérengère Salomé, et al. “CD56 as a Marker of an ILC1-like Population with NK Cell Properties That Is Functionally Impaired in AML.” Blood Advances, vol. 3, no. 22, Nov. 2019, pp. 3674–87. EBSCOhost, https://doi.org/10.1182/bloodadvances.2018030478.

APA

Bérengère Salomé, Alejandra Gomez-Cadena, Romain Loyon, Madeleine Suffiotti, Valentina Salvestrini, Tania Wyss, Giulia Vanoni, Dan Fu Ruan, Marianna Rossi, Alessandra Tozzo, Paolo Tentorio, Elena Bruni, Carsten Riether, Eva-Maria Jacobsen, Peter Jandus, Curdin Conrad, Manfred Hoenig, Ansgar Schulz, Katarzyna Michaud, … Camilla Jandus. (2019). CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML. Blood Advances, 3(22), 3674–3687. https://doi.org/10.1182/bloodadvances.2018030478

Chicago

Bérengère Salomé, Alejandra Gomez-Cadena, Romain Loyon, Madeleine Suffiotti, Valentina Salvestrini, Tania Wyss, Giulia Vanoni, et al. 2019. “CD56 as a Marker of an ILC1-like Population with NK Cell Properties That Is Functionally Impaired in AML.” Blood Advances 3 (22): 3674–87. doi:10.1182/bloodadvances.2018030478.